Cerevel Therapeutics Holdings Price Prediction

At the present time the value of rsi of Cerevel Therapeutics' share price is below 20 suggesting that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Oversold Vs Overbought

0

 
Oversold
 
Overbought
The successful prediction of Cerevel Therapeutics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Cerevel Therapeutics and does not consider all of the tangible or intangible factors available from Cerevel Therapeutics' fundamental data. We analyze noise-free headlines and recent hype associated with Cerevel Therapeutics Holdings, which may create opportunities for some arbitrage if properly timed.
Using Cerevel Therapeutics hype-based prediction, you can estimate the value of Cerevel Therapeutics Holdings from the perspective of Cerevel Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Cerevel Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Cerevel because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Cerevel Therapeutics after-hype prediction price

    
  USD 0.0  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Intrinsic
Valuation
LowRealHigh
0.000.000.00
Details
Naive
Forecast
LowNextHigh
0.330.330.33
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
-16.9726.8070.57
Details

Cerevel Therapeutics Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Cerevel Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cerevel Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Cerevel Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
9 Events / Month
15 Events / Month
In about 9 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.00
0.00
0.00 
0.00  
Notes

Cerevel Therapeutics Hype Timeline

Cerevel Therapeutics is currently traded for 0.00. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Cerevel is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Cerevel Therapeutics is about 0.0%, with the expected price after the next announcement by competition of 0.00. About 15.0% of the company shares are held by company insiders. The company recorded a loss per share of 2.73. Cerevel Therapeutics had not issued any dividends in recent years. The entity had 1:1 split on the 28th of October 2020. Given the investment horizon of 90 days the next projected press release will be in about 9 days.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Cerevel Therapeutics Related Hype Analysis

Having access to credible news sources related to Cerevel Therapeutics' direct competition is more important than ever and may enhance your ability to predict Cerevel Therapeutics' future price movements. Getting to know how Cerevel Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Cerevel Therapeutics may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
RNAAvidity Biosciences 0.13 12 per month 4.19 (0.01) 5.78 (7.08) 27.94 
RVMDRevolution Medicines 1.13 10 per month 2.04  0.12  4.81 (3.24) 10.95 
DAWNDay One Biopharmaceuticals 0.23 9 per month 2.72 (0.04) 3.84 (3.69) 11.44 
SWTXSpringWorks Therapeutics(1.08)11 per month 0.00 (0.05) 4.86 (4.36) 12.80 
VTYXVentyx Biosciences(0.18)8 per month 0.00 (0.03) 6.94 (5.86) 22.25 
NUVLNuvalent 0.63 10 per month 2.68  0.04  3.84 (4.61) 36.85 
TVTXTravere Therapeutics(0.30)11 per month 1.92  0.25  11.58 (4.13) 23.97 
GPCRStructure Therapeutics American(0.25)9 per month 0.00 (0.07) 8.18 (6.07) 24.50 
GLUEMonte Rosa Therapeutics(0.25)9 per month 3.86  0.08  10.11 (8.18) 102.66 
DSGNDesign Therapeutics(0.24)5 per month 5.31  0.04  9.61 (8.21) 35.31 
HOWLWerewolf Therapeutics(0.02)6 per month 4.85 (0.01) 9.21 (8.75) 49.02 
IKNAIkena Oncology(0.05)4 per month 1.39 (0.07) 1.81 (1.74) 13.50 
STOKStoke Therapeutics(0.04)10 per month 0.00 (0.09) 4.68 (6.99) 21.35 
APLSApellis Pharmaceuticals(1.10)9 per month 0.00 (0.13) 4.31 (5.17) 15.97 
TERNTerns Pharmaceuticals 0.30 8 per month 0.00 (0.09) 5.68 (5.96) 34.09 
BPMCBlueprint Medicines Corp(1.72)8 per month 2.61 (0.03) 4.90 (3.62) 14.28 
IGMSIGM Biosciences 0.83 9 per month 0.00 (0.02) 11.62 (9.42) 41.11 
CGEMCullinan Oncology LLC 1.25 10 per month 0.00 (0.17) 5.88 (7.24) 17.85 
MLYSMineralys Therapeutics, Common 0.14 8 per month 3.37  0.03  6.27 (5.79) 20.98 

Cerevel Therapeutics Additional Predictive Modules

Most predictive techniques to examine Cerevel price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cerevel using various technical indicators. When you analyze Cerevel charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Cerevel Therapeutics Predictive Indicators

The successful prediction of Cerevel Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Cerevel Therapeutics Holdings, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Cerevel Therapeutics based on analysis of Cerevel Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Cerevel Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Cerevel Therapeutics's related companies.

Story Coverage note for Cerevel Therapeutics

The number of cover stories for Cerevel Therapeutics depends on current market conditions and Cerevel Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Cerevel Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Cerevel Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Cerevel Therapeutics Short Properties

Cerevel Therapeutics' future price predictability will typically decrease when Cerevel Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Cerevel Therapeutics Holdings often depends not only on the future outlook of the potential Cerevel Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cerevel Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding162.1 M
Cash And Short Term Investments991 M
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Consideration for investing in Cerevel Stock

If you are still planning to invest in Cerevel Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cerevel Therapeutics' history and understand the potential risks before investing.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities